Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Calypte Biomedical Corporation (CALY) -- Ignore unavailable to you. Want to Upgrade?

To: John Lacelle who wrote (334)	2/9/1999 4:55:00 PM
From: Sherman Chen	Read Replies (1) \| Respond to of 381

Interesting post on Yahoo today, if true, it could explain the recent high volume. messages.yahoo.com@m2.yahoo.com

To: John Lacelle who wrote (334)	2/25/1999 11:37:00 AM
From: Cindy Powell	Read Replies (1) \| Respond to of 381

Dear John John, I have made most of my money with small biotechs as well, but you have to watch them with an eagle eye and keep on top of what is going on in within the industry. I think oral interferon is going to be a smash, and I am excited about the prospects for it's integration into the pharmaceutical arena. Oral drug delivery is really the best drug delivery in alot of cases, if these new drugs can be developed to bypass the liver and the digestive system. There are new methods for optimizing oral drug delivery that are exciting, as in the case of the new recently FDA approved micronized hormones that can bypass the digestive systems without being disabled or compromised. I think this is really significant news, and assures us that CALY has the potential for a broader based sales/product spectrum. Best regards, Cindy